Paper Details

  1. Home
  2. Paper Details

Cardiovascular Complications of Multiple Myeloma Treatment: Evaluation, Management, and Prevention.

Author: FradleyMichael G, LeeDae Hyun

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Multiple myeloma treatment regimens often include proteasome inhibitors, immunomodulatory drugs, and steroids, all of which can have adverse effects on the heart. This article discusses the cardiovascular complications associated with these treatment modalities and methods to mitigate them.
Paper Details　
Original Abstract of the Article :
Multiple myeloma treatment regimens consist of proteasome inhibitors (bortezomib, carfilzomib, and ixazomib), immunomodulatory drugs (thalidomide, lenalidomide, and pomalidomide), and steroids. In this paper, we will review the pathophysiology and associated cardiotoxicities of the different multipl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s11936-018-0618-y

データ提供：米国国立医学図書館（NLM）

Multiple Myeloma: Navigating the Desert of Cardiovascular Complications

Multiple myeloma, a cancer of plasma cells in the bone marrow, poses a significant challenge for patients and healthcare professionals. This study delves into the cardiovascular complications associated with multiple myeloma treatment, focusing on the various therapeutic modalities used to combat this disease. The authors provide an overview of the pathophysiology of these complications and present strategies for mitigating their development.

Cardiovascular Risks: A Challenging Terrain for Multiple Myeloma Patients

This study, like a desert explorer encountering treacherous sandstorms, highlights the cardiovascular risks associated with multiple myeloma treatment. The authors delve into the mechanisms by which different therapeutic modalities, such as proteasome inhibitors and immunomodulatory drugs, can impact cardiovascular health. The research emphasizes the importance of careful monitoring and proactive management to minimize cardiovascular complications and improve patient outcomes.

Health Implications and Lifestyle Applications

Individuals diagnosed with multiple myeloma should be aware of the potential cardiovascular complications associated with their treatment. It's essential to maintain a healthy lifestyle, including regular exercise, a balanced diet, and avoiding smoking. Consulting with a healthcare professional to discuss cardiovascular risk factors and strategies for mitigation is crucial for maintaining overall health and well-being.

Dr.Camel's Conclusion

The desert of multiple myeloma can be a challenging journey, with cardiovascular complications adding to the burden of this disease. This study serves as a guide for navigating this terrain, providing valuable insights into the mechanisms, risks, and management strategies for cardiovascular complications. By working closely with healthcare professionals and adopting healthy lifestyle practices, individuals can minimize these risks and improve their chances of a successful journey.

Date :
  1. Date Completed n.d.
  2. Date Revised 2020-10-01
Further Info :

Pubmed ID

29508087

DOI: Digital Object Identifier

10.1007/s11936-018-0618-y

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.